Adolescent use of combined hormonal contraception and peak bone mineral density accrual: A meta-analysis of international prospective controlled studies

Azita Goshtasebi, Tatjana Subotic Brajic, Delia Scholes, Tamara Beres Lederer Goldberg, Abbey Berenson, Jerilynn C. Prior

Research output: Contribution to journalReview article

Abstract

Objective: Many women use combined hormonal contraceptives (CHC) during adolescence during which they are accruing peak areal bone mineral density (BMD) that relates to lifetime fracture risk. To build BMD requires formation with which CHC-related exogenous oestrogen may interfere. We compared peak BMD accrual in adolescents using and not using CHC. Design/Participants: We performed literature searches for prospective published peer-reviewed articles providing 12- to 24-month BMD change in adolescent (12- to 19-year-old) women using CHC vs CHC-unexposed control women. Methods: Meta-analyses used random-effects models to assess BMD change rate at lumbar spine (LS) and other sites in adolescent CHC users vs CHC nonusers. Results: Literature searches yielded 84 publications of which nine were eligible. Adolescent-only data were sought from cohorts with wider age inclusions. The 12-month LS meta-analysis with eight paired comparisons in 1535 adolescents showed a weighted mean BMD difference of −0.02 (95% confidence interval [CI]: −0.05 to 0.00) g/cm 2 in CHC-exposed adolescents (P = 0.04). The 24-month LS meta-analysis with five paired comparisons in 885 adolescents showed a highly significant weighted mean BMD difference of −0.02 (95% CI: −0.03 to −0.01) g/cm 2 in CHC-exposed adolescents (P = 0.0006). Heterogeneities by I 2 were 96% and 85%, respectively. Insufficient data for other bone sites precluded quantitative analysis. Conclusion: Given that adolescent exposure to CHC appears to be increasing, this evidence for potential impairment of peak spinal BMD accrual is of concern and suggests a potential public health problem. Randomized controlled trial data are needed to determine CHC effects on adolescent bone health.

Original languageEnglish (US)
JournalClinical Endocrinology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Contraceptive Agents
Contraception
Bone Density
Meta-Analysis
Prospective Studies
Matched-Pair Analysis
Spine
Confidence Intervals
Bone and Bones
Publications
Estrogens
Randomized Controlled Trials
Public Health

Keywords

  • adolescence
  • combined hormonal contraception
  • lumbar spine
  • meta-analysis
  • osteoporosis
  • peak bone mineral density
  • prospective

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Adolescent use of combined hormonal contraception and peak bone mineral density accrual : A meta-analysis of international prospective controlled studies. / Goshtasebi, Azita; Subotic Brajic, Tatjana; Scholes, Delia; Beres Lederer Goldberg, Tamara; Berenson, Abbey; Prior, Jerilynn C.

In: Clinical Endocrinology, 01.01.2019.

Research output: Contribution to journalReview article

Goshtasebi, Azita ; Subotic Brajic, Tatjana ; Scholes, Delia ; Beres Lederer Goldberg, Tamara ; Berenson, Abbey ; Prior, Jerilynn C. / Adolescent use of combined hormonal contraception and peak bone mineral density accrual : A meta-analysis of international prospective controlled studies. In: Clinical Endocrinology. 2019.
@article{cd3752f71c8a455da91fa8dae31a8283,
title = "Adolescent use of combined hormonal contraception and peak bone mineral density accrual: A meta-analysis of international prospective controlled studies",
abstract = "Objective: Many women use combined hormonal contraceptives (CHC) during adolescence during which they are accruing peak areal bone mineral density (BMD) that relates to lifetime fracture risk. To build BMD requires formation with which CHC-related exogenous oestrogen may interfere. We compared peak BMD accrual in adolescents using and not using CHC. Design/Participants: We performed literature searches for prospective published peer-reviewed articles providing 12- to 24-month BMD change in adolescent (12- to 19-year-old) women using CHC vs CHC-unexposed control women. Methods: Meta-analyses used random-effects models to assess BMD change rate at lumbar spine (LS) and other sites in adolescent CHC users vs CHC nonusers. Results: Literature searches yielded 84 publications of which nine were eligible. Adolescent-only data were sought from cohorts with wider age inclusions. The 12-month LS meta-analysis with eight paired comparisons in 1535 adolescents showed a weighted mean BMD difference of −0.02 (95{\%} confidence interval [CI]: −0.05 to 0.00) g/cm 2 in CHC-exposed adolescents (P = 0.04). The 24-month LS meta-analysis with five paired comparisons in 885 adolescents showed a highly significant weighted mean BMD difference of −0.02 (95{\%} CI: −0.03 to −0.01) g/cm 2 in CHC-exposed adolescents (P = 0.0006). Heterogeneities by I 2 were 96{\%} and 85{\%}, respectively. Insufficient data for other bone sites precluded quantitative analysis. Conclusion: Given that adolescent exposure to CHC appears to be increasing, this evidence for potential impairment of peak spinal BMD accrual is of concern and suggests a potential public health problem. Randomized controlled trial data are needed to determine CHC effects on adolescent bone health.",
keywords = "adolescence, combined hormonal contraception, lumbar spine, meta-analysis, osteoporosis, peak bone mineral density, prospective",
author = "Azita Goshtasebi and {Subotic Brajic}, Tatjana and Delia Scholes and {Beres Lederer Goldberg}, Tamara and Abbey Berenson and Prior, {Jerilynn C.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/cen.13932",
language = "English (US)",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Adolescent use of combined hormonal contraception and peak bone mineral density accrual

T2 - A meta-analysis of international prospective controlled studies

AU - Goshtasebi, Azita

AU - Subotic Brajic, Tatjana

AU - Scholes, Delia

AU - Beres Lederer Goldberg, Tamara

AU - Berenson, Abbey

AU - Prior, Jerilynn C.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Many women use combined hormonal contraceptives (CHC) during adolescence during which they are accruing peak areal bone mineral density (BMD) that relates to lifetime fracture risk. To build BMD requires formation with which CHC-related exogenous oestrogen may interfere. We compared peak BMD accrual in adolescents using and not using CHC. Design/Participants: We performed literature searches for prospective published peer-reviewed articles providing 12- to 24-month BMD change in adolescent (12- to 19-year-old) women using CHC vs CHC-unexposed control women. Methods: Meta-analyses used random-effects models to assess BMD change rate at lumbar spine (LS) and other sites in adolescent CHC users vs CHC nonusers. Results: Literature searches yielded 84 publications of which nine were eligible. Adolescent-only data were sought from cohorts with wider age inclusions. The 12-month LS meta-analysis with eight paired comparisons in 1535 adolescents showed a weighted mean BMD difference of −0.02 (95% confidence interval [CI]: −0.05 to 0.00) g/cm 2 in CHC-exposed adolescents (P = 0.04). The 24-month LS meta-analysis with five paired comparisons in 885 adolescents showed a highly significant weighted mean BMD difference of −0.02 (95% CI: −0.03 to −0.01) g/cm 2 in CHC-exposed adolescents (P = 0.0006). Heterogeneities by I 2 were 96% and 85%, respectively. Insufficient data for other bone sites precluded quantitative analysis. Conclusion: Given that adolescent exposure to CHC appears to be increasing, this evidence for potential impairment of peak spinal BMD accrual is of concern and suggests a potential public health problem. Randomized controlled trial data are needed to determine CHC effects on adolescent bone health.

AB - Objective: Many women use combined hormonal contraceptives (CHC) during adolescence during which they are accruing peak areal bone mineral density (BMD) that relates to lifetime fracture risk. To build BMD requires formation with which CHC-related exogenous oestrogen may interfere. We compared peak BMD accrual in adolescents using and not using CHC. Design/Participants: We performed literature searches for prospective published peer-reviewed articles providing 12- to 24-month BMD change in adolescent (12- to 19-year-old) women using CHC vs CHC-unexposed control women. Methods: Meta-analyses used random-effects models to assess BMD change rate at lumbar spine (LS) and other sites in adolescent CHC users vs CHC nonusers. Results: Literature searches yielded 84 publications of which nine were eligible. Adolescent-only data were sought from cohorts with wider age inclusions. The 12-month LS meta-analysis with eight paired comparisons in 1535 adolescents showed a weighted mean BMD difference of −0.02 (95% confidence interval [CI]: −0.05 to 0.00) g/cm 2 in CHC-exposed adolescents (P = 0.04). The 24-month LS meta-analysis with five paired comparisons in 885 adolescents showed a highly significant weighted mean BMD difference of −0.02 (95% CI: −0.03 to −0.01) g/cm 2 in CHC-exposed adolescents (P = 0.0006). Heterogeneities by I 2 were 96% and 85%, respectively. Insufficient data for other bone sites precluded quantitative analysis. Conclusion: Given that adolescent exposure to CHC appears to be increasing, this evidence for potential impairment of peak spinal BMD accrual is of concern and suggests a potential public health problem. Randomized controlled trial data are needed to determine CHC effects on adolescent bone health.

KW - adolescence

KW - combined hormonal contraception

KW - lumbar spine

KW - meta-analysis

KW - osteoporosis

KW - peak bone mineral density

KW - prospective

UR - http://www.scopus.com/inward/record.url?scp=85061434521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061434521&partnerID=8YFLogxK

U2 - 10.1111/cen.13932

DO - 10.1111/cen.13932

M3 - Review article

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

ER -